FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Willerson

Research Profile

Disorders

Living Beings

Dogs

Anatomy

Physiology

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Xiaobing Liu; Su Pan; Toya Terry; James T Willerson; Zhongwei Yang; Richard A F Dixon; Qi Liu
Targeted delivery of carbaprostacyclin to ischemic hindlimbs enhances adaptive remodeling of the microvascular network.
Joshua M Hare; Timothy D Henry; Keith L March; Lemuel A Moyé; Michael P Murphy; Carl J Pepine; Emerson C Perin; Robert D Simari; Sonia I Skarlatos; Anita D Szady; Doris A Taylor; Jay H Traverse; Rachel W Vojvodic; James T Willerson; Phillip C Yang; Roberto Bolli; John P Cooke; David J Gordon
Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Network (CCTRN).
Rohan Bhavane; Darin Clark; Ketan B Ghaghada; G Allan Johnson; Anoosha Moturu; Deborah Vela; James T Willerson; Akshaya Annapragada; Cristian T Badea; Ananth V Annapragada
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Willerson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Xiaobing Liu; Su Pan; Toya Terry; James T Willerson; Zhongwei Yang; Richard A F Dixon; Qi Liu
Targeted delivery of carbaprostacyclin to ischemic hindlimbs enhances adaptive remodeling of the microvascular network.
Hypertension 2013;61(5):1036-43.
2013: Joshua M Hare; Timothy D Henry; Keith L March; Lemuel A Moyé; Michael P Murphy; Carl J Pepine; Emerson C Perin; Robert D Simari; Sonia I Skarlatos; Anita D Szady; Doris A Taylor; Jay H Traverse; Rachel W Vojvodic; James T Willerson; Phillip C Yang; Roberto Bolli; John P Cooke; David J Gordon
Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Network (CCTRN).
Circulation 2013;127(15):1630-5.
2013: Rohan Bhavane; Darin Clark; Ketan B Ghaghada; G Allan Johnson; Anoosha Moturu; Deborah Vela; James T Willerson; Akshaya Annapragada; Cristian T Badea; Ananth V Annapragada
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.
Circulation. Cardiovascular imaging 2013;6(2):285-94.
2013: Paolo Angelini; MacArthur A Elayda; Christine E Lawless; J Alberto Lopez; Mladen I Vidovich; Dwayne Wolf; James T Willerson
Preventing sudden cardiac death in athletes: in search of evidence-based, cost-effective screening.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2013;40(2):148-55.
2012: Emerson C Perin; James T Willerson
Buying new soul.
Journal of the American College of Cardiology 2012;60(21):2250-1.
2012: James T Willerson; Edward T H Yeh; Emerson C Perin
Cytokine profile and ST-elevation myocardial infarction.
Circulation research 2012;111(10):1256-7.
2012: Sara Richman; Robert D Simari; Doris A Taylor; Jay H Traverse; James T Willerson; David Zhao; Saif Anwaruddin; Jeannette Bloom; Christopher R Cogle; Diann Fisk; Adrian P Gee; Timothy D Henry; Jane Reese Koç; David H McKenna; Lemuel A Moyé; Carl J Pepine; Karen Prater; Sonia I Skarlatos
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion 2012;52(10):2225-33.
2012: Mehran Haidari; Ahmadreza Mortazavi; Christopher Stroud; James T Willerson; Darren G Woodside; Wei Zhang; Amy Caivano; Zhenping Chen; Leila Ganjehei; Richard A F Dixon
Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells.
The Journal of biological chemistry 2012;287(39):32981-92.
2012: Vincent E Friedewald; Joshua M Hare; Leslie W Miller; Howard T Walpole; James T Willerson; William C Roberts
The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease.
The American journal of cardiology 2012;110(6):807-16.
2012: Edward T H Yeh; James T Willerson
Heparin and bone marrow-derived cell therapy: friend or foe?
Circulation research 2012;111(7):819-20.
2012: Suet Nee Chen; Grazyna Czernuszewicz; J-P Jin; Raffaella Lombardi; Yanli Tan; James T Willerson; Ali J Marian
Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.
Circulation research 2012;111(7):907-19.
2012: Jose Francisco Islas; Dinakar Iyer; Yu Liu; Mark Mercola; Robert Glen Oshima; Vladimir N Potaman; Allan Prejusa; Matthew J Robertson; Dariya Tikhomirova; Kuo-Chan Weng; James T Willerson; Shuxing Zhang; Mani Chopra; John Harger; Robert J Schwartz
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(32):13016-21.
2012: Qi Liu; Xiaobing Liu; Anita Mohite; Ke-He Ruan; Shui-Ping So; Toya Terry; James T Willerson; Geru Wu; Yutao Xi; Jia Zhang; Jie Cheng; Richard A F Dixon
Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells.
Journal of cellular physiology 2012;227(7):2907-16.
2012: Ibrahim Aboshady; L Maximilian Buja; Dianna D Cody; Herbert L Dupont; Amir Gahremanpour; Evan M Johnson; Kamal G Khalil; Deborah Vela; James T Willerson; Gregory W Gladish
Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques.
International journal of cardiology 2012;156(3):295-302.
2012: Martin Rodriguez-Porcel; Jay H Traverse; James T Willerson; Stephen G Ellis; Timothy D Henry; Marvin W Kronenberg; Lemuel A Moyé; Carl J Pepine; Robert D Simari
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.
JACC. Cardiovascular imaging 2012;5(5):559-65.
2012: Emerson C Perin; Xin Quan; Guilherme V Silva; Yi Zheng; John Canales; Stephanie A Coulter; Marlos R Fernandes; Amir Gahremanpour; J Patrick Herlihy; Laurence H Keller; Warren H Moore; Dipsu Patel; James T Willerson
Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
American heart journal 2012;163(3):415-21, 421.e1.
2012: Salim S Virani; James T Willerson; James M Wilson; Elayda MacArthur; Eric Boerwinkle; Ariel Brautbar; Lorraine Frazier; Megan L Grove; Vei-Vei Lee; Alanna C Morrison; Vijay Nambi; Christie M Ballantyne
Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease.
Circulation journal : official journal of the Japanese Circulation Society 2012;76(4):950-6.
2012: Jingxiong Wang; James T Willerson; Juri G Gelovani; Amer Najjar; Brian Rabinovich; Sui Zhang; Edward T H Yeh
Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction.
Circulation. Cardiovascular imaging 2012;5(1):94-101.
2011: Gabriella Rodriguez; Aijing Z Starr; James T Willerson; Ahmad Alhariri; Grazyna Z Czernuszewicz; Kenneth W Mahaffey; Amit Manhas; Ali J Marian; Karen Pieper; Craig J Reist; Neal S Kleiman
Determinants of plasma vitamin D levels in patients with acute coronary syndromes.
European journal of clinical investigation 2011;41(12):1299-309.
2011: Emerson C Perin; Guilherme Silva; James T Willerson; Yi Zheng; Maria G Cabreira-Hansen; John Canales; Nicolas Chronos; Amir Gahremanpour; Rebecca Haley; Farrell Mendelsohn; Brian H Annex
A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;78(7):1060-7.
2011: C William Gundlach; Yi Zheng; Maria da Graca Cabreira-Hansen; Wells S Brown; Amy Caivano; Richard A F Dixon; Amir Gahremanpour; Bradley W McIntyre; Emerson C Perin; James T Willerson; Darren G Woodside
Synthesis and evaluation of an anti-MLC1 × anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium.
Bioconjugate chemistry 2011;22(8):1706-14.
2011: Emerson C Perin; James T Willerson
CD34+ autologous human stem cells in treating refractory angina.
Circulation research 2011;109(4):351-2.
2011: Gabriela Rodriguez; Yanli Tan; Tomomi Ueyama; James T Willerson; Katsuya Amano; Roberta Bogaev; Grazyna Czernuszewicz; Gerald W Dorn; Hiroaki Matsubara; Takehiro Ogata; Hidemasa Oh; Ali J Marian
Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy.
Circulation. Cardiovascular genetics 2011;4(4):349-58.
2011: Emerson C Perin; Guilherme V Silva; Timothy D Henry; Maria G Cabreira-Hansen; Warren H Moore; Stephanie A Coulter; J Patrick Herlihy; Marlos R Fernandes; Benjamin Y C Cheong; Scott D Flamm; Jay H Traverse; Yi Zheng; Deirdre Smith; Sandi Shaw; Lynette Westbrook; Rachel Olson; Dipsu Patel; Amir Gahremanpour; John Canales; William K Vaughn; James T Willerson
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).
American heart journal 2011;161(6):1078-87.e3.
2011: Salim S Virani; Ariel Brautbar; Vei-Vei Lee; Macarthur Elayda; Shehzad Sami; Vijay Nambi; Lorraine Frazier; James M Wilson; James T Willerson; Eric Boerwinkle; Christie M Ballantyne
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting.
The American journal of cardiology 2011;107(10):1504-9.
2011: Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.
European heart journal 2011;32(10):1190-6.
2011: James T Willerson
Imaging in electrical cardiac devices.
Journal of the American College of Cardiology 2011;57(7):829-30.
2011: Yong-Jian Geng; James T Willerson
Repairing the infarcted heart with stem cells from umbilical cord stroma.
Cardiology 2011;120(2):100-2.
2011: Guilherme V Silva; James T Willerson; Yi Zheng; Ricardo R Sanz; Franca S Angeli; Cristiano O Cardoso; Marlos R Fernandes; Pilar Jimenez-Quevedo; Javier Lopez; Edie M Oliveira; Emerson C Perin
A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2011;38(3):219-24.
2011: Toya Terry; Peter Vanderslice; James T Willerson; Pierre Zoldhelyi; Zhiqiang Chen; Richard A F Dixon; Qi Liu
CD34⁺/M-cadherin⁺ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE⁻/⁻ mice.
PloS one 2011;6(6):e20673.
2010: Lesa A Tran; Ramkumar Krishnamurthy; Raja Muthupillai; Maria da Graça Cabreira-Hansen; James T Willerson; Emerson C Perin; Lon J Wilson
Gadonanotubes as magnetic nanolabels for stem cell detection.
Biomaterials 2010;31(36):9482-91.
2010: Sherif F Nagueh; Raffaella Lombardi; Yanli Tan; Jianwen Wang; James T Willerson; Ali J Marian
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study.
European journal of clinical investigation 2010;40(11):976-83.
2010: Emerson C Perin; Guilherme V Silva; James T Willerson
Training on the use of transendocardial delivery of biologics for cardiac regeneration.
JACC. Cardiovascular interventions 2010;3(9):991.
2010: James T Willerson; Emerson C Perin; Stephen G Ellis; Carl J Pepine; Timothy D Henry; David X M Zhao; Dejian Lai; Marc S Penn; Barry J Byrne; Guilherme Silva; Adrian Gee; Jay H Traverse; Antonis K Hatzopoulos; John R Forder; Daniel Martin; Marvin Kronenberg; Doris A Taylor; Christopher R Cogle; Sarah Baraniuk; Lynette Westbrook; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moyé; Robert D Simari
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
American heart journal 2010;160(2):215-23.
2010: Jingxiong Wang; Sui Zhang; Brian Rabinovich; Luc Bidaut; Suren Soghomonyan; Mian M Alauddin; James Bankson; Elizabeth Shpall; James T Willerson; Juri G Gelovani; Edward T H Yeh
Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action.
Circulation research 2010;106(12):1904-11.
2010: Shun Kohsaka; Takeshi Kimura; Masashi Goto; Vei-Vei Lee; Macarthur Elayda; Yutaka Furukawa; Masanori Fukushima; Masashi Komeda; Ryuuzou Sakata; James T Willerson; James M Wilson; Toru Kita
Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database).
The American journal of cardiology 2010;105(12):1698-704.
2010: Ismail El-Hamamsy; James T Willerson; Magdi H Yacoub
Preserved homograft function 32 years after surgery in a young patient.
The Journal of thoracic and cardiovascular surgery 2010;139(6):e141-2.
2010: Harald C Eichstaedt; Qi Liu; Zhiqiang Chen; George C Bobustuc; Toya Terry; James T Willerson; Pierre Zoldhelyi
Gene transfer of COX-1 improves lumen size and blood flow in carotid bypass grafts.
The Journal of surgical research 2010;161(1):162-7.
2010: Salim S Virani; Vijay Nambi; Venkateshwar R Polsani; Vei-Vei Lee; MacArthur A Elayda; Shun Kohsaka; Wei Pan; Ross M Reul; James M Wilson; Laura A Petersen; James T Willerson; Christie M Ballantyne
Preoperative statin therapy decreases risk of postoperative renal insufficiency.
Cardiovascular therapeutics 2010;28(2):80-6.
2010: Vincent E Friedewald; Lawrence H Cohn; James P Kelly; Robert Roberts; Donald E Wesson; James T Willerson; Clyde W Yancy; William C Roberts
The Editor's Roundtable: Health reform and its implications for cardiovascular medicine.
The American journal of cardiology 2010;105(4):557-65.
2010: Robert D Simari; Lemuel A Moyé; Sonia I Skarlatos; Stephen G Ellis; David X M Zhao; James T Willerson; Timothy D Henry; Carl J Pepine
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
Journal of cardiovascular translational research 2010;3(1):30-6.
2010: Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Lara M Simpson; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Sarah Baraniuk; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moyè; Robert D Simari
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(4):412-20.
2010: Cheng-Huai Ruan; Richard A F Dixon; James T Willerson; Ke-He Ruan
Prostacyclin therapy for pulmonary arterial hypertension.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(4):391-9.
2010: Shehzad Sami; James T Willerson
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(3):262-75.
2010: Shehzad Sami; James T Willerson
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(2):141-8.
2010: Mohammad Madjid; Muzammil Ali; James T Willerson
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(1):25-39.
2010: James T Willerson
Texas Heart Institute Medal and The Ray C. Fish Award for Scientific Achievement in Cardiovascular Diseases.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2010;37(1):1-2.
2009: Yue-Jin Yang; Hai-Yan Qian; Ji Huang; Jian-Jun Li; Run-lin Gao; Ke-Fei Dou; Guo-Sheng Yang; James T Willerson; Yong-Jian Geng
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(12):2076-82.
2009: Paul M Ridker; Jean G MacFadyen; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
Circulation. Cardiovascular quality and outcomes 2009;2(6):616-23.
2009: Rosalinda Madonna; Harnath Shelat; Qun Xue; James T Willerson; Raffaele De Caterina; Yong-Jian Geng
Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha.
Experimental cell research 2009;315(17):2921-8.
2009: Qi Liu; Zhiqiang Chen; Toya Terry; Janice M McNatt; James T Willerson; Pierre Zoldhelyi
Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.
Vascular and endovascular surgery 2009;43(5):433-43.
2009: Lorraine Frazier; William K Vaughn; James T Willerson; Christie M Ballantyne; Eric Boerwinkle
Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events.
Biological research for nursing 2009;11(2):163-73.
2009: Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Douglas E Vaughn; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Linda B Piller; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moye'; Robert D Simari
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
American heart journal 2009;158(3):356-63.
2009: James T Willerson
Myocardial perfusion scintigraphy and value in patients with non-ST segment elevation acute coronary syndromes.
The American journal of cardiology 2009;104(5):738.
2009: Ariel Brautbar; Christie M Ballantyne; Kim Lawson; Vijay Nambi; Lloyd E Chambless; Aaron R Folsom; James T Willerson; Eric Boerwinkle
Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.
Circulation. Cardiovascular genetics 2009;2(3):279-85.
2009: Paul M Ridker; Vincent E Friedewald; Michael H Davidson; James T Willerson; William C Roberts
The editor's roundtable: the JUPITER trial--initial results and clinical implications.
The American journal of cardiology 2009;103(10):1417-25.
2009: Chu-Huang Chen; Richard A F Dixon; Liang-Yin Ke; James T Willerson
Vascular progenitor cells in diabetes mellitus: roles of Wnt signaling and negatively charged low-density lipoprotein.
Circulation research 2009;104(9):1038-40.
2009: Raffaella Lombardi; Jinjiang Dong; Gabriela Rodriguez; Achim Bell; Tack-Ki Leung; Robert J Schwartz; James T Willerson; Ramon Brugada; Ali J Marian
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Circulation research 2009;104(9):1076-84.
2009: Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
The New England journal of medicine 2009;360(18):1851-61.
2009: Paul M Ridker; Eleanor Danielson; Francisco Ah Fonseca; Jacques Genest; Antonio M Gotto; John Jp Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G Macfadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Lancet 2009;373(9670):1175-82.
2009: Raffaella Lombardi; Gabriela Rodriguez; Suet Nee Chen; Crystal M Ripplinger; Wenwen Li; Junjie Chen; James T Willerson; Sandro Betocchi; Samuel A Wickline; Igor Efimov; Ali J Marian
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
Circulation 2009;119(10):1398-407.
2009: Deborah C Vela; Guilherme V Silva; Joao A R Assad; Andre L S Sousa; Stephanie Coulter; Marlos R Fernandes; Emerson C Perin; James T Willerson; L Maximilian Buja
Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2009;57(2):167-76.
2009: Salim S Virani; Vijay Nambi; Vei-Vei Lee; MacArthur A Elayda; Wei Pan; Laura A Petersen; James M Wilson; James T Willerson; Christie M Ballantyne
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery?
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2009;36(6):540-5.
2009: James T Willerson; Greg Cable; Edward T H Yeh
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2009;36(6):530-9.
2009: Suet Nee Chen; Mehmet Cilingiroglu; Josh Todd; Raffaella Lombardi; James T Willerson; Antonio M Gotto; Christie M Ballantyne; A J Marian
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
BMC medical genetics 2009;10():111.
2008: Vincent E Friedewald; John A Ambrose; Gregory W Stone; William C Roberts; James T Willerson
The editor's roundtable: the vulnerable plaque.
The American journal of cardiology 2008;102(12):1644-53.
2008: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
The New England journal of medicine 2008;359(21):2195-207.
2008: Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
The use of high-sensitivity assays for C-reactive protein in clinical practice.
Nature clinical practice. Cardiovascular medicine 2008;5(10):621-35.
2008: Pilar Jiménez-Quevedo; Guillherme V Silva; Ricardo Sanz-Ruiz; Edie M Oliveira; Marlos R Fernandes; Franca Angeli; James T Willerson; Hans F Dohmann; Emerson C Perin
[Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients].
Revista española de cardiología 2008;61(6):635-9.
2008: Emerson C Perin; Guilherme V Silva; Joao A R Assad; Deborah Vela; L Maximilian Buja; Andre L S Sousa; Silvio Litovsky; Jing Lin; William K Vaughn; Stephanie Coulter; Marlos R Fernandes; James T Willerson
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.
Journal of molecular and cellular cardiology 2008;44(3):486-95.
2008: Shun Kohsaka; Kelly A Volcik; Aaron R Folsom; Kenneth K Wu; Christie M Ballantyne; James T Willerson; Eric Boerwinkle
Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study.
Atherosclerosis 2008;196(2):926-30.
2008: Alanna C Morrison; Lance A Bare; May M Luke; James S Pankow; Thomas H Mosley; James J Devlin; James T Willerson; Eric Boerwinkle
Single nucleotide polymorphisms associated with coronary heart disease predict incident ischemic stroke in the atherosclerosis risk in communities study.
Cerebrovascular diseases (Basel, Switzerland) 2008;26(4):420-4.
2008: James T Willerson
Passing of the editorship to Dr. James Willerson.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2008;35(1):2.
2008: Rosalinda Madonna; James T Willerson; Yong-Jian Geng
Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation.
Stem cells (Dayton, Ohio) 2008;26(1):202-11.
2007: Paul M Ridker; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Nardev S Khurmi; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Borge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
The American journal of cardiology 2007;100(11):1659-64.
2007: S David Gertz; Bernhard G Bodmann; Deborah Vela; Manos Papadakis; Ibrahim Aboshady; Paul Cherukuri; Simon Alexander; Donald Kouri; Shikha Baid; Alex A Gittens; Gregory W Gladish; Jodie (Jay) Conyers; Dianna D Cody; Lilach Gavish; Reza M Mazraeshahi; Wayne T Wilner; Lorraine Frazier; Mohammad Madjid; Alireza Zarrabi; Serhiy Lukovenkov; Amany Ahmed; James T Willerson; S Ward Casscells
Three-dimensional isotropic wavelets for post-acquisitional extraction of latent images of atherosclerotic plaque components from micro-computed tomography of human coronary arteries.
Academic radiology 2007;14(12):1509-19.
2007: Wayne T Wilner; Reza M Mazraeshahi; Ibrahim Aboshady; Bernhard G Bodmann; Manos Papadakis; Donald Kouri; Jodie (Jay) Conyers; Paul Cherukuri; Deborah Vela; Gregory W Gladish; Lilach Gavish; Dianna D Cody; Lorraine Frazier; Serhiy Lukovenkov; Mohammad Madjid; Alireza Zarrabi; Amany Ahmed; James T Willerson; S Ward Casscells; S David Gertz
Quantification of roughness of calcific deposits in computed tomography scans of human coronary arteries.
Investigative radiology 2007;42(11):771-6.
2007: Lance A Bare; Alanna C Morrison; Charles M Rowland; Dov Shiffman; May M Luke; Olga A Iakoubova; John P Kane; Mary J Malloy; Stephen G Ellis; James S Pankow; James T Willerson; James J Devlin; Eric Boerwinkle
Five common gene variants identify elevated genetic risk for coronary heart disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(10):682-9.
2007: Alanna C Morrison; Lance A Bare; Lloyd E Chambless; Stephen G Ellis; Mary J Malloy; John P Kane; James S Pankow; James J Devlin; James T Willerson; Eric Boerwinkle
Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study.
American journal of epidemiology 2007;166(1):28-35.
2007: Mohammad Madjid; Konstantinos Toutouzas; Christodoulos I Stefanadis; James T Willerson; S Ward Casscells
Coronary thermography for detection of vulnerable plaques.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2007;14(2):244-9.
2007: Adriana Osio; Lily Tan; Suet N Chen; Raffaella Lombardi; Sherif F Nagueh; Sanjay Shete; Robert Roberts; James T Willerson; Ali J Marian
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.
Circulation research 2007;100(6):766-8.
2007: Sui Zhang; Elizabeth J Shpall; James T Willerson; Edward T H Yeh
Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction.
Circulation research 2007;100(5):693-702.
2007: Deborah Vela; L Maximilian Buja; Mohammad Madjid; Alan Burke; Morteza Naghavi; James T Willerson; S Ward Casscells; Silvio Litovsky
The role of periadventitial fat in atherosclerosis.
Archives of pathology & laboratory medicine 2007;131(3):481-7.
2006: Abid Assali; Ali Moustapha; Stefano Sdringola; Ali E Denktas; James T Willerson; David R Holmes; Richard W Smalling
Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
The American journal of cardiology 2006;98(6):729-33.
2006: Yong-Jian Geng; Yue-Jin Yang; S Ward Casscells; James T Willerson
Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease.
Future cardiology 2006;2(5):585-92.
2006: Eduardo Garcia Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
The Journal of clinical investigation 2006;116(7):2012-21.
2006: Mohammad Madjid; James T Willerson; S Ward Casscells
Intracoronary thermography for detection of high-risk vulnerable plaques.
Journal of the American College of Cardiology 2006;47(8 Suppl):C80-5.
2006: Sotirios Tsimikas; James T Willerson; Paul M Ridker
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
Journal of the American College of Cardiology 2006;47(8 Suppl):C19-31.
2006: S David Gertz; Paul Cherukuri; Bernhard G Bodmann; Gregory W Gladish; Wayne T Wilner; Jodie (Jay) Conyers; Ibrahim Aboshady; Mohammad Madjid; Deborah Vela; Serhiy Lukovenkov; Manos Papadakis; Donald Kouri; Reza Mohammadi Mazraeshahi; Lorraine Frazier; Alireza Zarrabi; Donald Elrod; James T Willerson; S Ward Casscells
Usefulness of multidetector computed tomography for noninvasive evaluation of coronary arteries in asymptomatic patients.
The American journal of cardiology 2006;97(2):287-93.
2006: Mandeep Singh; Brent A Williams; Bernard J Gersh; Robyn L McClelland; Kalon K L Ho; James T Willerson; William F Penny; Donald E Cutlip; David R Holmes
Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
Journal of the American College of Cardiology 2006;47(1):34-9.
2005: Paolo Calabrò; Ismael Samudio; Stephen H Safe; James T Willerson; Edward T H Yeh
Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
Journal of vascular research 2005;42(6):509-16.
2005: James T Willerson; Edward T H Yeh; Yong-Jian Geng; Emerson C Perin
Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans.
Circulation research 2005;97(8):735-6.
2005: Paolo Calabro; David W Chang; James T Willerson; Edward T H Yeh
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation.
Journal of the American College of Cardiology 2005;46(6):1112-3.
2005: Heidar Arjomand; James T Willerson; David R Holmes; William R Bamlet; Satish K Surabhi; Bassam Roukoz; Andrey Espinoza; Robyn L McClelland; Daniel J McCormick; Sheldon Goldberg
Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
The American journal of cardiology 2005;96(6):741-6.
2005: Philippe Garot; Thierry Lefèvre; Michael Savage; Yves Louvard; William R Bamlet; James T Willerson; Marie-Claude Morice; David R Holmes
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
Journal of the American College of Cardiology 2005;46(4):606-12.
2005: Vinitha Senthil; Suet N Chen; Natalia Tsybouleva; Tripti Halder; Sherif F Nagueh; James T Willerson; Robert Roberts; Ali J Marian
Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Circulation research 2005;97(3):285-92.
2005: Hans F R Dohmann; Emerson C Perin; Christina M Takiya; Guilherme V Silva; Suzana Silva; Andre L S Sousa; Claudio T Mesquita; Maria Isabel D Rossi; Bernardo M O Pascarelli; Isabella M Assis; Helio S Dutra; Joao A R Assad; Rodrigo V Castello-Branco; Cantidio Drummond; Hans J F Dohmann; James T Willerson; Radovan Borojevic
Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.
Circulation 2005;112(4):521-6.
2005: Suet N Chen; Christie M Ballantyne; Antonio M Gotto; Yanli Tan; James T Willerson; Ali J Marian
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
Journal of the American College of Cardiology 2005;45(10):1611-9.
2005: Qi Liu; Zhi-Qiang Chen; George C Bobustuc; Janice M McNatt; Harry Segall; Su Pan; James T Willerson; Pierre Zoldhelyi
Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteries.
Circulation 2005;111(14):1833-40.
2005: Mandeep Singh; Bernard J Gersh; Robyn L McClelland; Kalon K L Ho; James T Willerson; William F Penny; David R Holmes
Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
Journal of the American College of Cardiology 2005;45(2):198-203.
2005: Guilherme V Silva; Silvio Litovsky; Joao A R Assad; Andre L S Sousa; Bradley J Martin; Deborah Vela; Stephanie C Coulter; Jing Lin; Judy Ober; William K Vaughn; Rodrigo V C Branco; Edie M Oliveira; Rumin He; Yong-Jian Geng; James T Willerson; Emerson C Perin
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.
Circulation 2005;111(2):150-6.
2004: Sui Zhang; Dachun Wang; Zeev Estrov; Sean Raj; James T Willerson; Edward T H Yeh
Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo.
Circulation 2004;110(25):3803-7.
2004: Paolo Calabro; Ismael Samudio; James T Willerson; Edward T H Yeh
Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.
Circulation 2004;110(21):3335-40.
2004: Mohammad Madjid; Imran Awan; James T Willerson; S Ward Casscells
Leukocyte count and coronary heart disease: implications for risk assessment.
Journal of the American College of Cardiology 2004;44(10):1945-56.
2004: Patricia J M Best; Peter B Berger; Barry R Davis; Cindy L Grines; H Mehrdad Sadeghi; Brent A Williams; James T Willerson; Jeffrey R Granett; David R Holmes
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial.
Journal of the American College of Cardiology 2004;44(9):1786-91.
2004: Richard J Popp; Sidney C Smith; Rober J Adams; Elliott M Antman; Rae-Ellen W Kavey; Anthony N DeMaria; Erik Ohman; Bertram Pitt; James T Willerson; Buce J Bellande; Gregg C Fonarow; Rick A Nishimura; Pravin M Shah; John W Hirshfeld; Joseph V Messer; eric peterson; Eric N Prystowsky; Jeffrey L Anderson; Melvin D Cheitlin; Larry B Goldstein; Augustus O Grant; George A Beller; Edward F Hines; David Wm Livingston; Christine W McEntree
ACCF/AHA consensus conference report on professionalism and ethics.
Circulation 2004;110(16):2506-49.
2004: Robert M Califf; Steven E Nissen; Anthony N DeMaria; Erik Ohman; Bertram Pitt; James T Willerson; David W Bilheimer; Jay N Cohn; David W Feigal; Lindsay Hampson; Beverly H Lorell; Carl J Pepine; Richard L Popp
Task force 2: Investigator participation in clinical research.
Journal of the American College of Cardiology 2004;44(8):1729-36.
2004: Mohammad Madjid; Alireza Zarrabi; Silvio Litovsky; James T Willerson; Ward Casscells
Finding vulnerable atherosclerotic plaques: is it worth the effort?
Arteriosclerosis, thrombosis, and vascular biology 2004;24(10):1775-82.
2004: Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana Silva; Andre L S Sousa; Guilherme V Silva; Claudio T Mesquita; Luciano Belém; William K Vaughn; Fernando O D Rangel; Joao A R Assad; Antonio C Carvalho; Rodrigo V C Branco; Maria Isabel D Rossi; Hans J F Dohmann; James T Willerson
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
Circulation 2004;110(11 Suppl 1):II213-8.
2004: James L Orford; Ali E Denktas; Brent A Williams; Panayotis Fasseas; James T Willerson; Peter B Berger; David R Holmes
Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes.
American heart journal 2004;148(3):501-6.
2004: Peter Libby; James T Willerson; Eugene Braunwald
C-reactive protein and coronary heart disease.
The New England journal of medicine 2004;351(3):295-8; author reply 295-8.
2004: Dean J Kereiakes; James T Willerson
Medical technology development and approval: the future is now.
Circulation 2004;109(25):3078-80.
2004: Dean J Kereiakes; James T Willerson
Health care on trial: America's medical malpractice crisis.
Circulation 2004;109(24):2939-41.
2004: Mandeep Singh; Bernard J Gersh; Robyn L McClelland; Kalon K L Ho; James T Willerson; William F Penny; David R Holmes
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial.
Circulation 2004;109(22):2727-31.
2004: James T Willerson; Paul M Ridker
Inflammation as a cardiovascular risk factor.
Circulation 2004;109(21 Suppl 1):II2-10.
2004: Dean J Kereiakes; James T Willerson
Doctors and hospitals: healthcare's Rubik's cube.
Circulation 2004;109(20):2381-5.
2004: Dean J Kereiakes; James T Willerson
US health care: entitlement or privilege?
Circulation 2004;109(12):1460-2.
2004: Reynolds M Delgado; Mohamad A Nawar; Aly M Zewail; Biswajit Kar; William K Vaughn; Kenneth K Wu; Nena Aleksic; Natarajan Sivasubramanian; Kathleen McKay; Douglas L Mann; James T Willerson
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure.
Circulation 2004;109(11):1428-33.
2004: Dean J Kereiakes; James T Willerson
The United States cardiovascular care deficit.
Circulation 2004;109(7):821-3.
2004: Harvey D White; James T Willerson
We must use the knowledge that we have to treat patients with acute coronary syndromes.
Circulation 2004;109(6):698-700.
2004: Verghese Mathew; Bernard J Gersh; Brent A Williams; Warren K Laskey; James T Willerson; R Thomas Tilbury; Barry R Davis; David R Holmes
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Circulation 2004;109(4):476-80.
2004: James T Willerson; Dean J Kereiakes
Cardiac resynchronization therapy: helpful now in selected patients with CHF.
Circulation 2004;109(3):308-9.
2004: Guilherme V Silva; Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana Silva; Andre L S Sousa; Joao A R Assad; William K Vaughn; Claudio T Mesquita; Luciano Belém; Antonio C Carvalho; Hans J F Dohmann; Ellen Barroso do Amaral; Joaquim Coutinho; Rodrigo V C Branco; Edie Oliveira; James T Willerson
Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2004;31(3):214-9.
2004: James T Willerson
The great enemy--infectious disease.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2004;31(1):1.
2003: James T Willerson; Dean J Kereiakes
Editors' commentary: mechanical circulatory support.
Circulation 2003;108(25):3069-70.
2003: Dean J Kereiakes; James T Willerson
Therapeutic substitution: guilty until proven innocent.
Circulation 2003;108(21):2611-2.
2003: James T Willerson; Dean J Kereiakes
Endothelial dysfunction.
Circulation 2003;108(17):2060-1.
2003: Edward T H Yeh; Sui Zhang; Henry D Wu; Martin Körbling; James T Willerson; Zeev Estrov
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo.
Circulation 2003;108(17):2070-3.
2003: Paolo Calabró; James T Willerson; Edward T H Yeh
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.
Circulation 2003;108(16):1930-2.
2003: Dean J Kereiakes; James T Willerson
Metabolic syndrome epidemic.
Circulation 2003;108(13):1552-3.
2003: James T Willerson; Dean J Kereiakes
Clinical research and future improvement in clinical care: the Health Insurance Portability and Accountability Act (HIPAA) and future difficulties but optimism for the way forward.
Circulation 2003;108(8):919-20.
2003: Dean J Kereiakes; James T Willerson
Vascular brachytherapy boon or bust?
Circulation 2003;108(4):389-90.
2003: Eric J Topol; Donald Easton; Robert A Harrington; Pierre Amarenco; Robert M Califf; Carmelo Graffagnino; Stephen Davis; Hans-Christophe Diener; James Ferguson; Desmond Fitzgerald; Jeffrey Granett; Ashfaq Shuaib; Peter J Koudstaal; Pierre Theroux; Frans Van de Werf; Kristina N Sigmon; Karen Pieper; Marc Vallee; James T Willerson
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Circulation 2003;108(4):399-406.
2003: Eugene S Chung; Milton Packer; Kim Hung Lo; Adedigbo A Fasanmade; James T Willerson
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.
Circulation 2003;107(25):3133-40.
2003: James T Willerson
Editor's commentary: One size does not fit all.
Circulation 2003;107(20):2543-4.
2003: Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana Silva; Andre L S Sousa; Claudio T Mesquita; Maria Isabel D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong-Jian Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
Circulation 2003;107(18):2294-302.
2003: Morteza Naghavi; Mohammad Madjid; Khawar Gul; Mir S Siadaty; Silvio Litovsky; James T Willerson; S Ward Casscells
Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;59(1):52-9.
2003: Ward Casscells; Morteza Naghavi; James T Willerson
Vulnerable atherosclerotic plaque: a multifocal disease.
Circulation 2003;107(16):2072-5.
2003: Silvio Litovsky; Mohammad Madjid; Alireza Zarrabi; S Ward Casscells; James T Willerson; Morteza Naghavi
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma.
Circulation 2003;107(11):1545-9.
2003: James T Willerson
Editor's commentary: centers of excellence.
Circulation 2003;107(11):1471-2.
2003: Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Ted McCluskey
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
Circulation 2003;107(10):1359-65.
2003: Emerson C Perin; Yong-Jian Geng; James T Willerson
Adult stem cell therapy in perspective.
Circulation 2003;107(7):935-8.
2003: Edward T H Yeh; James T Willerson
Coming of age of C-reactive protein: using inflammation markers in cardiology.
Circulation 2003;107(3):370-1.
2002: A Adrián González; Ana M Segura; Koji Horiba; Sujuan Qian; Zu-Xi Yu; William Stetler-Stevenson; James T Willerson; Hugh A McAllister; Victor J Ferrans
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
Human pathology 2002;33(12):1158-64.
2002: Mohammad Madjid; Morteza Naghavi; Basit A Malik; Silvio Litovsky; James T Willerson; Ward Casscells
Thermal detection of vulnerable plaque.
The American journal of cardiology 2002;90(10C):36L-39L.
2002: Min Chen; Carrie Capps; James T Willerson; Pierre Zoldhelyi
E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1.
Circulation 2002;106(21):2707-13.
2002: Robert Bonow; Edward B Clark; Gregory D Curfman; Alan Guttmacher; Martha N Hill; D Craig Miller; Aubrey R Morrison; Robert J Myerburg; Michael D Schneider; Myron L Weisfeldt; James T Willerson; James B Young
Task Force on Strategic Research Direction: Clinical Science Subgroup key science topics report.
Circulation 2002;106(20):e162-6.
2002: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; Philippe Gabriel STEG; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Alireza Zarrabi; Khawar Gul; James T Willerson; Ward Casscells; Morteza Naghavi
Intravascular thermography: a novel approach for detection of vulnerable plaque.
Current opinion in cardiology 2002;17(6):656-62.
2002: David R Holmes; Michael Savage; Jean-Marc LaBlanche; Lars Grip; P W Serruys; Peter Fitzgerald; David Fischman; Sheldon Goldberg; Jeffrey A Brinker; A M Zeiher; Leonard M Shapiro; James T Willerson; Barry R Davis; James J Ferguson; Jeffrey J Popma; Spencer B King; A Michael Lincoff; James E Tcheng; Robert Chan; Jeffrey R Granett; Marcia Poland
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Circulation 2002;106(10):1243-50.
2002: Morteza Naghavi; Reji John; Sameh Naguib; Mir S Siadaty; Roxana Grasu; K C Kurian; W Barry van Winkle; Babs Soller; Silvio Litovsky; Mohammad Madjid; James T Willerson; Ward Casscells
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque.
Atherosclerosis 2002;164(1):27-35.
2002: Bertram Pitt; Carl Pepine; James T Willerson
Cyclooxygenase-2 inhibition and cardiovascular events.
Circulation 2002;106(2):167-9.
2002: James T Willerson
Systemic and local inflammation in patients with unstable atherosclerotic plaques.
Progress in cardiovascular diseases 2002;44(6):469-78.
2002: Jing Wang; Yong-Jian Geng; Bujin Guo; Tomas Klima; Birendra N Lal; James T Willerson; Ward Casscells
Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques.
Journal of the American College of Cardiology 2002;39(8):1305-13.
2002: Paolo Golino; Filippo Crea; James T Willerson
How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
Italian heart journal : official journal of the Italian Federation of Cardiology 2002;3(4):220-5.
2002: James T Willerson; Filippo Crea
How to search for the precipitating role of vasoconstriction and its prevalence in myocardial infarction.
Italian heart journal : official journal of the Italian Federation of Cardiology 2002;3(4):217-9.
2002: James T Willerson
March 26, 2002: rapid access publication.
Circulation 2002;105(12):1395.
2001: H Vernon Anderson; Janice M McNatt; Fred Clubb; M Herman; J P Maffrand; F DeClerck; Chul Ahn; L Maximilian Buja; James T Willerson
Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
Circulation 2001;104(19):2331-7.
2001: V Pasceri; J S Cheng; James T Willerson; Edward T H Yeh; J Chang
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.
Circulation 2001;103(21):2531-4.
2001: Pierre Zoldhelyi; Zhi-Qiang Chen; Harnath S Shelat; Janice M McNatt; James T Willerson
Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4078-83.
2001: R J Lefkowitz; James T Willerson
Prospects for cardiovascular research.
JAMA : the journal of the American Medical Association 2001;285(5):581-7.
2001: Harnath S Shelat; T J Liu; D L Hickman-Bick; M K Barnhart; Thomas Vida; P M Dillard; James T Willerson; Pierre Zoldhelyi
Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1.
Circulation 2001;103(3):407-14.
2001: Fred Clubb; J L Cerny; DA Deferrari; M M Butler-Aucoin; James T Willerson; L Maximilian Buja
Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2001;10(1):1-11.
2000: T W Jax; H C Eichstaedt; Harnath S Shelat; M K Barnhart; M W Lichtenberg; James T Willerson; Pierre Zoldhelyi
[New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy].
Zeitschrift für Kardiologie 2000;89(12):1072-83.
2000: Pierre Zoldhelyi; PJ Beck; RJ Bjercke; J C Ober; X Hu; Janice M McNatt; S Akhtar; M Ahmed; F J Clubb; Zhi-Qiang Chen; Richard A F Dixon; Edward T H Yeh; James T Willerson
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor.
American journal of physiology. Heart and circulatory physiology 2000;279(6):H3065-75.
2000: V Pasceri; James T Willerson; Edward T H Yeh
Direct proinflammatory effect of C-reactive protein on human endothelial cells.
Circulation 2000;102(18):2165-8.
2000: Eric J Topol; J Donald Easton; P Amarenco; Robert M Califf; Robert A Harrington; Carmelo Graffagnino; S Davis; H C Diener; J Ferguson; D Fitzgerald; Ashfaq Shuaib; Peter J Koudstaal; Pierre Theroux; Frans Van de Werf; James T Willerson; R Chan; R Samuels; B Ilson; Jeffrey Granett
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
American heart journal 2000;139(6):927-33.
2000: Pierre Zoldhelyi; Janice M McNatt; Harnath S Shelat; Y Yamamoto; Zhi-Qiang Chen; James T Willerson
Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor.
Circulation 2000;101(3):289-95.
2000: V Pasceri; H D Wu; James T Willerson; Edward T H Yeh
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.
Circulation 2000;101(3):235-8.
2000: D Holmes; P Fitzgerald; S Goldberg; Jean-Marc LaBlanche; A Michael Lincoff; M Savage; P W Serruys; James T Willerson; Jeffrey R Granett; R Chan; N H Shusterman; M Poland
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial.
American heart journal 2000;139(1 Pt 1):23-31.
1999: Pierre Zoldhelyi; H Eichstaedt; T Jax; Janice M McNatt; Zhi-Qiang Chen; Harnath S Shelat; H Rose; James T Willerson
The emerging clinical potential of cardiovascular gene therapy.
Seminars in interventional cardiology : SIIC 1999;4(3):151-65.
1999: James T Willerson; Pierre Zoldhelyi
Future directions in thrombolysis.
Clinical cardiology 1999;22(8 Suppl):IV44-53.
1998: A M Segura; R E Luna; Koji Horiba; William Stetler-Stevenson; Hugh A McAllister; James T Willerson; Victor J Ferrans
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
Circulation 1998;98(19 Suppl):II331-7; discussion II337-8.
1998: S S Patel; R Thiagarajan; James T Willerson; Edward T H Yeh
Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice.
Circulation 1998;97(1):75-81.
1997: Rajbabu Pakala; James T Willerson; Claude R Benedict
Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
Circulation 1997;96(7):2280-6.
1997: K Fujise; B M Revelle; L Stacy; E L Madison; Edward T H Yeh; James T Willerson; PJ Beck
A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent.
Circulation 1997;95(3):715-22.
1996: James T Willerson; S R Igo; S K Yao; J C Ober; MP Macris; J J Ferguson
Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1996;23(1):1-8.
1996: Pierre Zoldhelyi; J McNatt; X M Xu; D Loose-Mitchell; Robert S Meidell; F J Clubb; L Maximilian Buja; James T Willerson; Kenneth K Wu
Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene.
Circulation 1996;93(1):10-7.
1995: H Vernon Anderson; C P Cannon; P H Stone; D O Williams; C H McCabe; G L Knatterud; B Thompson; James T Willerson; E Braunwald
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Journal of the American College of Cardiology 1995;26(7):1643-50.
1995: H Vernon Anderson; R L Kirkeeide; James T Willerson; D C Mishkel; O Kjellgren; Richard W Smalling; G Schroth
Coronary artery flow monitoring following coronary interventions.
European heart journal 1995;16 Suppl J():71-3.
1995: S K Yao; S Akhtar; Timothy Scott-Burden; J C Ober; Paolo Golino; L Maximilian Buja; W Casscells; James T Willerson
Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis.
Circulation 1995;92(4):1005-10.
1995: H W Mueller; C A Haught; J M McNatt; K Cui; S J Gaskell; D A Johnston; James T Willerson
Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
Circulation research 1995;77(1):54-63.
1995: A L McGhie; Tracy L Faber; James T Willerson; James R Corbett
Evaluation of left ventricular aneurysm after acute myocardial infarction using tomographic radionuclide ventriculography.
The American journal of cardiology 1995;75(10):720-4.
1995: Kenneth K Wu; Pierre Zoldhelyi; James T Willerson; Robert S Meidell; J McNatt; X M Xu
Restoration of prostacyclin synthesis by transfer of prostaglandin H synthase cDNA.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():377-9.
1995: James T Willerson; Pierre Zoldhelyi; Robert S Meidell; J McNatt; X M Xu; Kenneth K Wu
Gene therapy to restore prostacyclin presence to injured endothelium.
Transactions of the American Clinical and Climatological Association 1995;106():100-7; discussion 107-8.
1994: A I McGhie; J McNatt; N Ezov; K Cui; L K Mower; Y Hagay; L Maximilian Buja; L I Garfinkel; M Gorecki; James T Willerson
Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
Circulation 1994;90(6):2976-81.
1994: Rajbabu Pakala; James T Willerson; Claude R Benedict
Mitogenic effect of serotonin on vascular endothelial cells.
Circulation 1994;90(4):1919-26.
1994: S K Yao; J C Ober; J J Ferguson; J P Maffrand; H Vernon Anderson; L Maximilian Buja; James T Willerson
Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis.
The American journal of physiology 1994;267(2 Pt 2):H488-93.
1994: James T Willerson
James B. Herrick Memorial Lecture.
Circulation 1994;89(4):1875-81.
1994: James T Willerson; S K Yao; J McNatt; K Cui; H Vernon Anderson; C Swensen; M Ostro; L Maximilian Buja
Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
Circulation 1994;89(4):1786-91.
1994: H Vernon Anderson; R L Kirkeeide; A Krishnaswami; L A Weigelt; M Revana; H F Weisman; James T Willerson
Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody.
Journal of the American College of Cardiology 1994;23(5):1031-7.
1994: Richard W Smalling; M Sweeney; B Lachterman; M J Hess; R Morris; H Vernon Anderson; J Heibig; G Li; James T Willerson; H Frazier
Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. Evidence for recovery from near fatal myocardial stunning.
Journal of the American College of Cardiology 1994;23(3):637-44.
1994: Paolo Golino; Federico Piscione; Claude R Benedict; H Vernon Anderson; M Cappelli-Bigazzi; Ciro Indolfi; Mario Condorelli; M Chiariello; James T Willerson
Local effect of serotonin released during coronary angioplasty.
The New England journal of medicine 1994;330(8):523-8.
1994: Kenneth K Wu; Pierre Zoldhelyi; James T Willerson; X M Xu; D S Loose-Mitchell; L H Wang
Gene therapy for vascular diseases.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1994;21(1):98-103.
1994: Claude R Benedict; Rajbabu Pakala; James T Willerson
Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1994;21(1):86-90.
1994: W Casscells; D Engler; James T Willerson
Mechanisms of restenosis.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1994;21(1):68-77.
1993: S K Yao; J McNatt; K Cui; H Vernon Anderson; J P Maffrand; L Maximilian Buja; James T Willerson
Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates.
Circulation 1993;88(6):2888-93.
1993: S K Yao; J C Ober; A Gonenne; F J Clubb; A Krishnaswami; J J Ferguson; H Vernon Anderson; M Gorecki; L Maximilian Buja; James T Willerson
Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.
Circulation research 1993;73(5):952-67.
1993: James T Willerson; L Maximilian Buja
A 17-year-old woman with a history of sexually transmitted disease and productive cough who developed cardiogenic shock.
Circulation 1993;88(4 Pt 1):1945-51.
1993: H Vernon Anderson; James T Willerson
Thrombolysis in acute myocardial infarction.
The New England journal of medicine 1993;329(10):703-9.
1993: James T Willerson; P C Chen; E A Hartwell; L Maximilian Buja
Congestive heart failure in a 70-year-old man.
Circulation 1993;88(3):1336-47.
1993: James T Willerson; A M Guthrie; L Maximilian Buja
Chest pain in a 26-year-old woman with a history of systemic lupus erythematosus and hypertension.
Circulation 1993;88(2):787-96.
1993: H Vernon Anderson; R L Kirkeeide; Y Stuart; Richard W Smalling; J Heibig; James T Willerson
Coronary artery flow monitoring following coronary interventions.
The American journal of cardiology 1993;71(14):62D-69D.
1993: S K Yao; J C Ober; J J Ferguson; J P Maffrand; H Vernon Anderson; L Maximilian Buja; James T Willerson
Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis.
Transactions of the Association of American Physicians 1993;106():110-9.
1992: S K Yao; J C Ober; J J Ferguson; H Vernon Anderson; J Maraganore; L Maximilian Buja; James T Willerson
Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
Circulation 1992;86(6):1993-9.
1992: S K Yao; J C Ober; A Krishnaswami; J J Ferguson; H Vernon Anderson; Paolo Golino; L Maximilian Buja; James T Willerson
Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Circulation 1992;86(4):1302-9.
1992: F T Thandroyen; D Bellotto; A Katayama; Herbert Hagler; James T Willerson; L Maximilian Buja
Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes.
Circulation research 1992;71(1):106-19.
1992: H Vernon Anderson; M Revana; O Rosales; L Brannigan; Y Stuart; H Weisman; James T Willerson
Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty.
The American journal of cardiology 1992;69(16):1373-6.
1992: S K Yao; J McNatt; H Vernon Anderson; J Eidt; K X Cui; Paolo Golino; P Glas-Greenwalt; J Maraganore; L Maximilian Buja; James T Willerson
Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.
The American journal of physiology 1992;262(2 Pt 2):H374-9.
1991: James T Willerson; S K Yao; J McNatt; Claude R Benedict; H Vernon Anderson; Paolo Golino; S S Murphree; L Maximilian Buja
Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10624-8.
1991: A I McGhie; James T Willerson; James R Corbett
Radionuclide assessment of ventricular function and risk stratification after myocardial infarction.
Circulation 1991;84(3 Suppl):I167-76.
1991: F T Thandroyen; A C Morris; Herbert Hagler; B Ziman; L Pai; James T Willerson; L Maximilian Buja
Intracellular calcium transients and arrhythmia in isolated heart cells.
Circulation research 1991;69(3):810-9.
1991: James T Willerson; J F Eidt; J McNatt; S K Yao; Paolo Golino; H Vernon Anderson; L Maximilian Buja
Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
Journal of the American College of Cardiology 1991;17(6 Suppl B):101B-110B.
1991: S K Yao; Claude R Benedict; M Rosolowsky; J McNatt; B Falinska; W B Campbell; L Maximilian Buja; James T Willerson
Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
Journal of molecular and cellular cardiology 1991;23(4):473-82.
1991: James T Willerson; Paolo Golino; J McNatt; J Eidt; S K Yao; L Maximilian Buja
Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.
Molecular biology & medicine 1991;8(2):235-43.
1991: Paolo Golino; Federico Piscione; James T Willerson; M Cappelli-Bigazzi; A Focaccio; Bruno Villari; Ciro Indolfi; E Russolillo; Mario Condorelli; M Chiariello
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients.
The New England journal of medicine 1991;324(10):641-8.
1991: A I McGhie; James R Corbett; M S Akers; P Kulkarni; M N Sills; M Kremers; L Maximilian Buja; M Durant-Reville; RW Parkey; James T Willerson
Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction.
The American journal of cardiology 1991;67(4):236-42.
1991: James T Willerson; Paolo Golino; J McNatt; J Eidt; S K Yao; L Maximilian Buja
Role of new antiplatelet agents as adjunctive therapies in thrombolysis.
The American journal of cardiology 1991;67(3):12A-18A.
1991: Paolo Golino; James T Willerson
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1991;18(1):50-61.
1991: J J Ferguson; J C Ober; S K Edelman; L Maximilian Buja; James T Willerson
Documentation of experimentally induced thrombus formation using intravascular ultrasound.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1991;18(3):179-85.
1991: James T Willerson; S K Yao; J J Ferguson; H Vernon Anderson; Paolo Golino; L Maximilian Buja
Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1991;18(4):243-7.
1991: James T Willerson
Serotonin and thrombotic complications.
Journal of cardiovascular pharmacology 1991;17 Suppl 5():S13-20.
1990: James T Willerson; Paolo Golino; J Eidt; S K Yao; L Maximilian Buja
Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes.
The American journal of cardiology 1990;66(16):48G-53G.
1990: Paolo Golino; M Rosolowsky; S K Yao; J McNatt; F De Clerck; L Maximilian Buja; James T Willerson
Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
The Journal of clinical investigation 1990;86(4):1095-102.
1990: James T Willerson
Technetium-99m MIBI as a myocardial perfusion agent.
Circulation 1990;82(3):1067-9.
1990: L Maximilian Buja; R A Fattor; J C Miller; K R Chien; James T Willerson
Effects of calcium loading and impaired energy production on metabolic and ultrastructural features of cell injury in cultured neonatal rat cardiac myocytes.
Laboratory investigation; a journal of technical methods and pathology 1990;63(3):320-31.
1990: S K Yao; M Rosolowsky; H Vernon Anderson; Paolo Golino; J M NcNatt; F De Clerck; L Maximilian Buja; James T Willerson
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Journal of the American College of Cardiology 1990;16(3):705-13.
1990: F T Thandroyen; K H Muntz; L Maximilian Buja; James T Willerson
Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion.
Circulation 1990;82(3 Suppl):II30-7.
1990: L Maximilian Buja; F J Clubb; D W Bilheimer; James T Willerson
Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit.
European heart journal 1990;11 Suppl E():41-52.
1990: James T Willerson; Paolo Golino; J Eidt; S Yao; L Maximilian Buja
Evidence that combined thromboxane A2 and serotonin receptor blockade might prevent coronary artery thrombosis and the conversion from chronic to acute coronary heart disease syndromes.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(2):211-8.
1990: James T Willerson; L Maximilian Buja
Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy.
The American journal of cardiology 1990;65(19):35I-41I.
1990: A L Taylor; Paolo Golino; R Eckels; P Pastor; L Maximilian Buja; James T Willerson
Differential enhancement of postischemic segmental systolic thickening by diltiazem.
Journal of the American College of Cardiology 1990;15(3):737-47.
1990: M Rosolowsky; John R Falck; James T Willerson; W B Campbell
Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries.
Circulation research 1990;66(3):608-21.
1990: Paolo Golino; L Maximilian Buja; S K Yao; J McNatt; James T Willerson
Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Journal of the American College of Cardiology 1990;15(3):718-26.
1990: J K Kahn; M N Sills; James R Corbett; James T Willerson
What is the current role of nuclear cardiology in clinical medicine?
Chest 1990;97(2):442-6.
1990: James T Willerson; L Maximilian Buja
Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 1990;17(3):157-64.
1990: S K Yao; J M McNatt; H Vernon Anderson; J F Eidt; K X Cui; Paolo Golino; P Glas-Greenwalt; J M Maraganore; L Maximilian Buja; James T Willerson
Thrombin inhibition and coronary artery thrombolysis.
Transactions of the Association of American Physicians 1990;103():1-9.
1989: J F Eidt; J Ashton; Paolo Golino; J McNatt; L Maximilian Buja; James T Willerson
Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.
The American journal of physiology 1989;257(3 Pt 2):H873-82.
1989: ronald peshock; R Rokey; G M Malloy; P McNamee; L Maximilian Buja; RW Parkey; James T Willerson
Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging.
Journal of the American College of Cardiology 1989;14(3):653-9.
1989: D Parsons; K P Burton; Herbert Hagler; James T Willerson; L Maximilian Buja
Tension and electrolyte changes with Na+-K+ pump inhibition in rat papillary muscle.
The American journal of physiology 1989;257(3 Pt 2):H942-53.
1989: R L Jones; J C Miller; Herbert Hagler; K R Chien; James T Willerson; L Maximilian Buja
Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes.
The American journal of pathology 1989;135(3):541-56.
1989: J F Eidt; J Ashton; Paolo Golino; J McNatt; L Maximilian Buja; James T Willerson
Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
The Journal of clinical investigation 1989;84(2):517-27.
1989: F J Clubb; J M Schmitz; M M Butler; L Maximilian Buja; James T Willerson; W B Campbell
Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Arteriosclerosis (Dallas, Tex.) 1989;9(4):529-37.
1989: J F Eidt; P Allison; S Noble; J Ashton; Paolo Golino; J McNatt; L Maximilian Buja; James T Willerson
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
The Journal of clinical investigation 1989;84(1):18-27.
1989: James T Willerson; Paolo Golino; J Eidt; W B Campbell; L Maximilian Buja
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
Circulation 1989;80(1):198-205.
1989: J K Kahn; I McGhie; M S Akers; M N Sills; Tracy L Faber; PV Kulkarni; James T Willerson; James R Corbett
Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.
Circulation 1989;79(6):1282-93.
1989: A C Morris; Herbert Hagler; James T Willerson; L Maximilian Buja
Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes.
The Journal of clinical investigation 1989;83(6):1876-87.
1989: F T Thandroyen; K Muntz; T Rosenbaum; B Ziman; James T Willerson; L Maximilian Buja
Beta-receptor-adenylate cyclase coupling in hypoxic neonatal rat ventricular myocytes.
The American journal of physiology 1989;256(4 Pt 2):H1209-17.
1989: Paolo Golino; J H Ashton; J McNatt; P Glas-Greenwalt; S K Yao; R A O'Brien; L Maximilian Buja; James T Willerson
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Circulation 1989;79(4):911-9.
1989: P A Wines; J M Schmitz; S L Pfister; F J Clubb; L Maximilian Buja; James T Willerson; W B Campbell
Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbit.
Arteriosclerosis (Dallas, Tex.) 1989;9(2):195-202.
1989: J H Ashton; Paolo Golino; J M McNatt; L Maximilian Buja; James T Willerson
Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
Journal of the American College of Cardiology 1989;13(3):755-63.
1989: Paolo Golino; J H Ashton; L Maximilian Buja; M Rosolowsky; A L Taylor; J McNatt; W B Campbell; James T Willerson
Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.
Circulation 1989;79(1):154-66.
1988: W McBride; J D Jackman; R S Gammon; James T Willerson
High-output cardiac failure in patients with multiple myeloma.
The New England journal of medicine 1988;319(25):1651-3.
1988: Saul Schaefer; C R Malloy; J Katz; RW Parkey; L Maximilian Buja; James T Willerson; ronald peshock
Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk.
Journal of the American College of Cardiology 1988;12(4):1064-72.
1988: S L Pfister; J M Schmitz; James T Willerson; W B Campbell
Characterization of arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and New Zealand white (NZW) rabbit aortas.
Prostaglandins 1988;36(4):515-32.
1988: A Sen; J C Miller; R Reynolds; James T Willerson; L Maximilian Buja; K R Chien
Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion.
The Journal of clinical investigation 1988;82(4):1333-8.
1988: Paolo Golino; L Maximilian Buja; J H Ashton; P Kulkarni; A Taylor; James T Willerson
Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Circulation 1988;78(3):701-11.
1988: Paolo Golino; J H Ashton; P Glas-Greenwalt; J McNatt; L Maximilian Buja; James T Willerson
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Circulation 1988;77(3):678-84.
1988: James T Willerson; L Maximilian Buja
Myocardial cellular alterations during myocardial ischemia and evolving infarction.
Postgraduate medicine 1988;Spec No():69-75.
1988: James T Willerson; L Maximilian Buja
Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarction.
Postgraduate medicine 1988;Spec No():27-32.
1988: J F Eidt; P Allison; S Noble; J Ashton; Paolo Golino; J McNatt; L Maximilian Buja; James T Willerson
Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
Transactions of the Association of American Physicians 1988;101():125-36.
1988: L Maximilian Buja; K P Burton; K R Chien; James T Willerson
Altered calcium homeostasis and membrane integrity in myocardial cell injury.
Advances in experimental medicine and biology 1988;232():115-24.
1987: P G Apprill; J Ashton; J Guerrero; P Glas-Greenwalt; L Maximilian Buja; James T Willerson
Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis.
American heart journal 1987;113(4):898-906.
1987: D E Jansen; James R Corbett; L Maximilian Buja; C Hansen; V Ugolini; RW Parkey; James T Willerson
Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.
Circulation 1987;75(3):611-7.
1986: P L Kennedy; James R Corbett; PV Kulkarni; C L Wolfe; D E Jansen; C L Hansen; L Maximilian Buja; RW Parkey; James T Willerson
Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.
Circulation 1986;74(5):1007-15.
1986: J H Ashton; J M Schmitz; W B Campbell; Martin Ogletree; S Raheja; A L Taylor; C Fitzgerald; L Maximilian Buja; James T Willerson
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Circulation research 1986;59(5):568-78.
1986: J H Ashton; C R Benedict; C Fitzgerald; S Raheja; A Taylor; W B Campbell; L Maximilian Buja; James T Willerson
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.
Circulation 1986;73(3):572-8.
1985: C L Wolfe; D E Jansen; James R Corbett; K Lipscomb; G Gabliani; N Filipchuk; G Redish; S E Lewis; James T Willerson
Determination of left ventricular mass using single-photon emission computed tomography.
The American journal of cardiology 1985;56(12):761-4.
1985: L Maximilian Buja; Herbert Hagler; D Parsons; K Chien; R C Reynolds; James T Willerson
Alterations of ultrastructure and elemental composition in cultured neonatal rat cardiac myocytes after metabolic inhibition with iodoacetic acid.
Laboratory investigation; a journal of technical methods and pathology 1985;53(4):397-412.
1985: L R Bush; L Maximilian Buja; G Tilton; M Wathen; P Apprill; J Ashton; James T Willerson
Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs.
Circulation 1985;72(2):413-30.
1985: J M Schmitz; P G Apprill; L Maximilian Buja; James T Willerson; W B Campbell
Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Circulation research 1985;57(2):223-31.
1985: P Apprill; J M Schmitz; W B Campbell; G Tilton; J Ashton; S Raheja; L Maximilian Buja; James T Willerson
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Circulation 1985;72(2):397-405.
1985: G D Tilton; L Maximilian Buja; D W Bilheimer; P Apprill; J Ashton; J McNatt; T Kita; James T Willerson
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
Journal of the American College of Cardiology 1985;6(1):141-4.
1985: G D Tilton; L R Bush; P G Apprill; L Maximilian Buja; James T Willerson
Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs.
Circulation 1985;71(1):165-75.
1984: James T Willerson; W B Campbell; M D Winniford; J Schmitz; P Apprill; B G Firth; J Ashton; T Smitherman; L Bush; L Maximilian Buja
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
The American journal of cardiology 1984;54(10):1349-54.
1984: James R Corbett; S E Lewis; C L Wolfe; D E Jansen; M Lewis; J S Rellas; RW Parkey; R E Rude; L Maximilian Buja; James T Willerson
Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography.
The American journal of cardiology 1984;54(10):1231-6.
1984: L R Bush; W B Campbell; Karl B Kern; G D Tilton; P Apprill; J Ashton; J Schmitz; L Maximilian Buja; James T Willerson
The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Circulation research 1984;55(5):642-52.
1984: J S Rellas; J Sokolov; James R Corbett; S E Lewis; James T Willerson
Radionuclide ventriculography: usefulness in evaluating alterations in ventricular function.
Journal of molecular and cellular cardiology 1984;16(8):695-708.
1984: J Mukharji; S Murray; S E Lewis; C H Croft; James R Corbett; James T Willerson; R E Rude
Is anterior ST depression with acute transmural inferior infarction due to posterior infarction? A vectorcardiographic and scintigraphic study.
Journal of the American College of Cardiology 1984;4(1):28-34.
1984: L R Bush; W B Campbell; L Maximilian Buja; G D Tilton; James T Willerson
Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Circulation 1984;69(6):1161-70.
1984: R E Rude; L R Bush; C Izquierdo; L Maximilian Buja; James T Willerson
Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. III. Influence of basal heart rate.
The American journal of cardiology 1984;53(11):1688-94.
1984: James R Corbett; M Lewis; James T Willerson; P H Nicod; R L Huxley; T Simon; R E Rude; E Henderson; RW Parkey; J S Rellas
99mTc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay.
Circulation 1984;69(6):1120-8.
1984: P Nicod; James R Corbett; C F Sanford; J Mukharji; G J Dehmer; C H Croft; R E Rude; S Lewis; James T Willerson
Comparison of the influence of acute transmural and nontransmural myocardial infarction on ventricular function.
American heart journal 1984;107(1):28-34.
1983: J S Rellas; James R Corbett; P Kulkarni; C Morgan; Michael D Devous; L Maximilian Buja; L Bush; RW Parkey; James T Willerson; S E Lewis
Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography.
The American journal of cardiology 1983;52(10):1326-32.
1983: D R Mauritson; S M Johnson; M D Winniford; J R Cary; James T Willerson; L D Hillis
Verapamil for unstable angina at rest: a short-term randomized, double-blind study.
American heart journal 1983;106(4 Pt 1):652-8.
1983: R E Rude; C Izquierdo; L R Bush; L Maximilian Buja; James T Willerson
Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. II. Studies with dopamine and ouabain in the barbiturate-anesthetized dog.
Journal of cardiovascular pharmacology 1983;5(5):717-24.
1983: L R Bush; L Maximilian Buja; W Samowitz; R E Rude; M Wathen; G D Tilton; James T Willerson
Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs. Comparison of 2- and 4-hour occlusions.
Circulation research 1983;53(2):248-63.
1983: P Nicod; James R Corbett; B G Firth; S E Lewis; R E Rude; R Huxley; James T Willerson
Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease.
The American journal of cardiology 1983;52(1):30-6.
1983: R L Huxley; F A Gaffney; James R Corbett; B G Firth; R Peshock; P Nicod; J S Rellas; G Curry; S E Lewis; James T Willerson
Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy.
The American journal of cardiology 1983;51(9):1542-50.
1983: James R Corbett; P H Nicod; R L Huxley; S E Lewis; R E Rude; James T Willerson
Left ventricular functional alterations at rest and during submaximal exercise in patients with recent myocardial infarction.
The American journal of medicine 1983;74(4):577-91.
1983: L R Bush; W B Campbell; G D Tilton; L Maximilian Buja; James T Willerson
Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
Transactions of the Association of American Physicians 1983;96():103-12.
1983: R L Huxley; James R Corbett; S E Lewis; James T Willerson
Radionuclide ventriculography to evaluate myocardial function.
Advances in experimental medicine and biology 1983;161():267-303.
1982: M D Winniford; S M Johnson; D R Mauritson; J S Rellas; G A Redish; James T Willerson; L D Hillis
Verapamil therapy for Prinzmetal's variant angina: comparison with placebo and nifedipine.
The American journal of cardiology 1982;50(4):913-8.
1982: C H Croft; P Nicod; James R Corbett; S E Lewis; R Huxley; J Mukharji; James T Willerson; R E Rude
Detection of acute right ventricular infarction by right precordial electrocardiography.
The American journal of cardiology 1982;50(3):421-7.
1982: C H Croft; W Woodward; P Nicod; James R Corbett; S E Lewis; James T Willerson; R E Rude
Clinical implications of anterior S-T segment depression in patients with acute inferior myocardial infarction.
The American journal of cardiology 1982;50(3):428-36.
1982: R E Rude; C Izquierdo; L Maximilian Buja; James T Willerson
Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog.
Circulation 1982;65(7):1321-8.
1982: L R Bush; L Maximilian Buja; W Samowitz; R E Rude; James T Willerson
Recovery of left ventricular segmental function following temporary coronary occlusion.
Transactions of the Association of American Physicians 1982;95():94-103.
1982: S M Johnson; D R Mauritson; M D Winniford; James T Willerson; B G Firth; J R Cary; L D Hillis
Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis.
American heart journal 1982;103(1):4-12.
1981: S M Johnson; D R Mauritson; James R Corbett; W Woodward; James T Willerson; L D Hillis
Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris.
The American journal of medicine 1981;71(3):443-51.
1981: James R Corbett; G J Dehmer; S E Lewis; W Woodward; E Henderson; R W Parkey; Gunnar C Blomqvist; James T Willerson
The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction.
Circulation 1981;64(3):535-44.
1981: S M Johnson; D R Mauritson; James T Willerson; J R Cary; L D Hillis
Verapamil administration in variant angina pectoris. Efficacy shown by ecg monitoring.
JAMA : the journal of the American Medical Association 1981;245(18):1849-51.
1980: James T Willerson; P Kulkarni; M Stone; S E Lewis; E Eigenbrodt; F J Bonte; R W Parkey; L Maximilian Buja
Localization of anti-mitochondrial antibody in experimental canine myocardial infarcts.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(11):6856-9.